FDA Adverse Event Malfunction Summary report: N

INSIGNIA

MDR report key: 4140502 · Received October 3, 2014

Report

Report Number
2124215-2014-17298
Event Type
Malfunction
Date Received
October 3, 2014
Date of Event
September 12, 2014
Report Date
September 29, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
PMA / PMN Number
D970003
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). ANALYSIS OF THE RETURNED PRODUCT IS CURRENTLY ONGOING. THIS EVENT WILL BE UPDATED UPON COMPLETION OF THE ANALYSIS.

Additional Manufacturer Narrative · 1

(B)(4). UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE DEVICE WAS PERFORMED. A VISUAL INSPECTION OF THE DEVICE HEADER AND CASE NOTED NO ANOMALIES. THE DEVICE WAS THEN EXPOSED TO SIMULATED HEART LOAD CONDITIONS, AND THE PACING AND SENSING FUNCTIONS WERE TESTED. THE DEVICE OPERATED APPROPRIATELY, ACCORDING TO ITS PERFORMANCE SPECIFICATIONS, WITH NO INTERRUPTIONS IN THERAPY OUTPUT OR PROGRAMMER COMMUNICATION AT THE RETURNED PROGRAMMED SETTINGS. A SERIES OF ELECTRICAL TESTS WAS ALSO PERFORMED, AND AGAIN, NORMAL DEVICE FUNCTION WAS OBSERVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT NOISE WAS PRESENT ON THE DEVICE AND RIGHT ATRIAL (RA) LEAD. ADDITIONALLY, RA PACING IMPEDANCE MEASUREMENTS WERE GREATER THAN 2,000 OHMS IN BIPOLAR CONFIGURATION. IN UNIPOLAR CONFIGURATION, PACING IMPEDANCE MEASUREMENTS WERE WITHIN ACCEPTABLE LIMITS. A REVISION PROCEDURE WAS PERFORMED AND THE DEVICE WAS EXPLANTED DUE TO NORMAL BATTERY DEPLETION. THE RA LEAD REMAINS ACTIVELY IMPLANTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED DURING THE PROCEDURE. THE DEVICE WAS RETURNED TO ALLOW FOR RELIABILITY ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
618857 INSIGNIA IMPLANTABLE PULSE GENERATOR LWP GUIDANT CRM CLONMEL IRELAND 1298

Patients

Seq Age Sex Outcome Treatment
1 84 YR K063| 4087| 4086| 1298